• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Assay Integrity of a PCR Influenza Point-of-Care Test Remains Following Artificial System Contamination

tetano

Editor, Senior Moderator
J Appl Lab Med. 2019 Nov;4(3):422-426. doi: 10.1373/jalm.2018.028639. Epub 2019 Jul 1. [h=1]Assay Integrity of a PCR Influenza Point-of-Care Test Remains Following Artificial System Contamination.[/h]
Phillips JE[SUP]1[/SUP], McCune S[SUP]1[/SUP], Fantz CR[SUP]1[/SUP], Engstrom-Melnyk J[SUP]1[/SUP], Osiecki JC[SUP]2[/SUP].
[h=3]Author information[/h] 1 Roche Diagnostics Corporation, Indianapolis, IN. 2 Roche Diagnostics Corporation, Indianapolis, IN. john.osiecki@roche.com.

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Healthcare providers who have access to tests at the point of care (POC) are increasingly requesting the same performance from the POC test as they expect from the laboratory. With the introduction of the cobas[SUP]?[/SUP] Liat instrument, highly sensitive molecular diagnostic testing can be performed closer to the patient in CLIA-waived, POC settings. As more sensitive tests become available, there is concern regarding contamination of instrumentation owing to improper handling, mistakes made when processing, or environmental contamination. Recent concerns were raised when a nurse performed environmental surveillance for flu A/B by inserting a dry swab into the cobas Liat instrument and then ran it as a sample on the instrument, generating a positive result. This finding stimulated questions about the possibility of system contamination contributing to false-positive results, ultimately leading to the possibility of providing incorrect treatment to patients.
[h=4]METHODS:[/h] To assess the likelihood of system contamination contributing to the generation of false-positive results, in this study we contaminated a cobas Liat System with flu A/B-positive control material. The system contamination was then assessed by swabbing exposed surfaces. Following confirmed system contamination, negative control samples were processed to determine whether system contamination had an impact on the expected negative results.
[h=4]RESULTS:[/h] Instrument contamination was confirmed, and no detectable flu A/B signal was observed for any of the negative control tubes run immediately following confirmation of system contamination.
[h=4]CONCLUSION:[/h] Environmental contamination of the Liat instrument does not have an impact on the integrity of the result.
? 2019 American Association for Clinical Chemistry.


PMID: 31659080 DOI: 10.1373/jalm.2018.028639
 
Back
Top Bottom